How to buy Cronos shares

Own Cronos shares in just a few minutes.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Cronos Group Inc is a drug manufacturers-specialty & generic business with stocks listed in the US. Cronos shares (CRON) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$8.56 – a decrease of 4.99% over the previous week. Here's how to invest if you're based in Australia.

How to buy shares in Cronos

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Cronos. Find the share by name or ticker symbol: CRON. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cronos reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of US$8.56, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Cronos, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Cronos. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Cronos share price

Use our graph to track the performance of CRON stocks over time.

Cronos shares at a glance

Information last updated 2021-06-17.
52-week rangeUS$4.915 - US$15.83
50-day moving average US$8.0576
200-day moving average US$9.223
Target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) US$0.287

Compare share trading platforms to buy stock

Name Product Standard brokerage for US shares Inactivity fee Currency conversion fee Markets
eToro (US, EU stock trading)
US$0
US$10 per month if there’s been no login for 12 months
0.50%
Global shares, US shares, ETFs
Zero brokerage share trading on US stocks with trades as low as $50.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
Finder Award
IG Share Trading
US$0
$50 per quarter if you make fewer than three trades in that period
0.70%
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
US$9.9
No
0.75%
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Acess 19,000+ stocks on 37 exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Stockbroking
US$0
No
0.60%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
loading

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Cronos stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Cronos price performance over time

Historical closes compared with the last close of $8.56

1 week (2021-06-15) -1.83%
1 month (2021-05-21) 15.99%
3 months (2021-03-22) -12.21%
6 months (2020-12-22) 12.93%
1 year (2020-06-22) 32.71%
2 years (2019-06-21) -46.30%
3 years (2018-06-22) 18.23%

Cronos financials

Revenue TTM US$50.9 million
Gross profit TTM US$-25,833,000
Return on assets TTM -5.51%
Return on equity TTM -19%
Profit margin 0%
Book value 4.226
Market capitalisation US$3.2 billion

TTM: trailing 12 months

Shorting Cronos shares

There are currently 20.7 million Cronos shares held short by investors – that's known as Cronos's "short interest". This figure is 2.8% down from 21.3 million last month.

There are a few different ways that this level of interest in shorting Cronos shares can be evaluated.

Cronos's "short interest ratio" (SIR)

Cronos's "short interest ratio" (SIR) is the quantity of Cronos shares currently shorted divided by the average quantity of Cronos shares traded daily (recently around 2.8 million). Cronos's SIR currently stands at 7.38. In other words for every 100,000 Cronos shares traded daily on the market, roughly 7380 shares are currently held short.

However Cronos's short interest can also be evaluated against the total number of Cronos shares, or, against the total number of tradable Cronos shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cronos's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Cronos shares in existence, roughly 60 shares are currently held short) or 0.1054% of the tradable shares (for every 100,000 tradable Cronos shares, roughly 105 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Cronos.

Find out more about how you can short Cronos stock.

Cronos share dividends

We're not expecting Cronos to pay a dividend over the next 12 months.

Cronos share price volatility

Over the last 12 months, Cronos's shares have ranged in value from as little as US$4.915 up to US$15.83. A popular way to gauge a stock's volatility is its "beta".

CRON.US volatility(beta: 1.83)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cronos's is 1.8266. This would suggest that Cronos's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Cronos overview

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site
Not sure what platform to go with?
Take this quick quiz to find the right share trading platform